NAMS logo

NewAmsterdam Pharma Company N.V. (NAMS)

Profile

Full Name

NewAmsterdam Pharma Company N.V.

Ticker

NASDAQ: NAMS

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Netherlands

IPO

February 9, 2021

Indexes

Not included

Website

https://www.newamsterdampharma.com

Employees

77

Key Details

Price

$24.84(+1.31%)

Market cap

$2.80B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$45.56M(+223.37% YoY)

Annual EPS

-$2.56(-19.07% YoY)

PE ratio

-

Next earnings date

Nov 5, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $24.84
    NAMS price is $24.84

    30-Day Relative Volume

    0.58
    NAMS 30-day relative volume is 0.58

    Price Performance

    Price Today change

    +1.31%
    NAMS price is up +1.31% today

    Price YTD change

    -3.35%
    NAMS price is down -3.35% since January 1st

    Price 1-year change

    +60.78%
    NAMS price is up +60.78% year-on-year

    Price 3-year change

    +149.15%
    NAMS price is up +149.15% over the past 3 years

    Price Range

    Price All-time high

    $32.88
    NAMS price is currently -24.45% below its historical high of $32.88

    Price 3-year low

    $5.63
    NAMS price is currently +340.97% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $2.80B
    NAMS market capitalization is $2.80 billion

    Market cap 3-year change

    +1862.18%
    NAMS market capitalization is up +1862.18% over the past 3 years

    Market cap All-time high

    $3.04B
    NAMS market capitalization is currently -8.00% below its historical high of $3.04 billion

    Market cap sector rank

    84.31%
    NAMS market capitalization is higher than 84.31% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +25.12%
    NAMS shares outstanding is up +25.12% year-on-year

    Shares Outstanding 3-Year Change

    +687.56%
    NAMS shares outstanding is up +687.56% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.96
    NAMS beta is 0.96

    200-day SMA

    $21.44
    NAMS price is currently +15.84% above its 200-day simple moving average

    50-day SMA

    $23.77
    NAMS price is currently +4.50% above its 50-day simple moving average

    RSI

    49.08
    NAMS 14-day relative strength index is 49.08

    Volume

    0.58
    NAMS 30-day relative volume is 0.58

    ATR

    $1.43
    NAMS average true range is $1.43

    10-day Historical Volatility

    77.01%
    NAMS 10-day historical volatility is 77.01%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $45.56M
    NAMS annual revenue is $45.56 million

    Revenue Analysts estimate

    $27.20M
    NAMS annual revenue is currently +67.54% higher than the consensus analysts' forecast

    Revenue 1-year change

    +223.37%
    NAMS annual revenue is up +223.37% year-on-year

    Revenue Sector rank

    60.82%
    NAMS annual revenue is higher than 60.82% of companies in Healthcare sector

    EPS

    EPS

    -$2.56
    NAMS annual earnings per share is -$2.56

    EPS Analysts estimate

    -$1.20
    NAMS annual earnings per share is currently +114.10% higher than the consensus analysts' forecast

    EPS 1-year change

    -19.07%
    NAMS annual earnings per share is down -19.07% year-on-year

    EPS Sector rank

    33.08%
    NAMS annual earnings per share is higher than 33.08% of companies in Healthcare sector

    Profit

    Gross profit

    $45.45M
    NAMS annual gross profit is $45.45 million

    Gross margin

    99.75%
    NAMS annual gross profit margin is 99.75%

    Operating profit

    -$176.29M
    NAMS annual operating income is -$176.29 million

    Operating margin

    -386.91%
    NAMS annual operating profit margin is -386.91%

    Net income

    -$241.60M
    NAMS annual net profit is -$241.60 million

    Net margin

    -530.25%
    NAMS annual net profit margin is -530.25%

    Expenses

    Total expenses

    $221.85M
    NAMS annual total expenses is $221.85 million

    Operating expenses

    $221.85M
    NAMS annual total operating expenses is $221.85 million

    Cost of goods sold

    $113.00K
    NAMS annual cost of goods sold is $113.00 thousand

    Selling, general & administrative expenses

    $70.45M
    NAMS annual SGA is $70.45 million

    Depreciation and amortization

    $113.00K
    NAMS annual depreciation & amortization is $113.00 thousand

    Interest expense

    $0.00
    NAMS annual interest expense is $0.00

    Income tax

    -$1000.00
    NAMS annual income tax is -$1000.00

    EBIT & EBITDA

    EBIT

    -$241.60M
    NAMS annual earnings before interest & taxes is -$241.60 million

    EBITDA

    -$241.49M
    NAMS annual EBITDA is -$241.49 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $864.62M
    NAMS annual total assets is $864.62 million

    Non current assets

    $1.21M
    NAMS annual long term assets is $1.21 million

    Current assets

    $863.41M
    NAMS annual total current assets is $863.41 million

    Cash and cash equivalents

    $771.74M
    NAMS annual cash & cash equivalents is $771.74 million

    Accounts receivable

    -
    NAMS annual accounts receivable value is unknown

    Inventory

    $0.00
    NAMS annual inventory is $0.00

    Liabilities

    Total liabilities

    $107.12M
    NAMS annual total liabilities is $107.12 million

    Long term liabilities

    $202.00K
    NAMS annual total long term liabilities is $202.00 thousand

    Current liabilities

    $106.92M
    NAMS annual total current liabilities is $106.92 million

    Accounts payable

    $4.74M
    NAMS annual accounts payable is $4.74 million

    Debt

    Total debt

    $448.00K
    NAMS annual total debt is $448.00 thousand

    Total debt 1-year change

    +646.67%
    NAMS annual total debt is up +646.67% year-on-year

    Long term debt

    $202.00K
    NAMS annual long term debt is $202.00 thousand

    Short term debt

    $246.00K
    NAMS annual short term debt is $246.00 thousand

    Equity & Capital

    Shareholders equity

    $757.50M
    NAMS annual stockholders equity is $757.50 million

    Book value

    $757.50M
    NAMS annual book value is $757.50 million

    Retained earnings

    -$558.57M
    NAMS annual retained earnings is -$558.57 million

    Working capital

    $756.50M
    NAMS annual working capital is $756.50 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$158.56M
    NAMS annual cash flow from operations is -$158.56 million

    Cash from operations 1-year change

    -12.28%
    NAMS annual cash flow from operations is down -12.28% year-on-year

    Cash from investing

    -$62.85M
    NAMS annual cash flow from investing activities is -$62.85 million

    Cash from investing 1-year change

    -261766.67%
    NAMS annual cash flow from investing activities is down -261766.67% year-on-year

    Cash from financing

    $659.51M
    NAMS annual cash flow from financing activities is $659.51 million

    Cash from financing 1-year change

    +7300.21%
    NAMS annual cash flow from financing activities is up +7300.21% year-on-year

    CAPEX

    CAPEX

    $672.00K
    NAMS annual capital expenditures is $672.00 thousand

    CAPEX 1-year change

    +2700%
    NAMS annual capital expenditures is up +2700% year-on-year

    Free Cash Flow

    Free cash flow

    -$159.24M
    NAMS annual free cash flow is -$159.24 million

    Free cash flow 1-year change

    -12.74%
    NAMS annual free cash flow is down -12.74% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    99.75%
    NAMS annual gross profit margin is 99.75%

    Operating margin

    -386.91%
    NAMS annual operating profit margin is -386.91%

    Net margin

    -530.25%
    NAMS annual net profit margin is -530.25%

    ROA & ROE

    ROA

    -39.88%
    NAMS annual return on assets is -39.88%

    ROE

    -46.20%
    NAMS annual return on equity is -46.20%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    NAMS price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    NAMS price to earnings ratio is unknown

    PB Ratio

    PB ratio

    3.59
    NAMS price to book ratio is 3.59

    PB ratio Sector rank

    70.14%
    NAMS price to book ratio is higher than 70.14% of companies in Healthcare sector

    PS Ratio

    PS ratio

    43.71
    NAMS price to sales ratio is 43.71

    PS ratio Sector rank

    86.01%
    NAMS price to sales ratio is higher than 86.01% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $2.06B
    NAMS enterprise value is $2.06 billion

    Enterprise value Sector rank

    80.71%
    NAMS enterprise value is higher than 80.71% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -11.97
    NAMS EV/EBITDA is -11.97

    EV/EBITDA Sector rank

    12.2%
    NAMS EV/EBITDA is higher than 12.2% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    8.08
    NAMS annual current ratio is 8.08

    Quick ratio

    8.08
    NAMS annual quick ratio is 8.08

    Leverage

    Debt to equity

    0.00
    NAMS annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    NAMS annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    5
    NAMS piotroski f-score is 5

    Altman Z-Score

    14.95
    NAMS altman z-score is 14.95

    Analyst ratings

    Recent major analysts updates

    Aug 25, 25 Wells Fargo
    Overweight
    Aug 7, 25 RBC Capital
    Outperform
    Jul 17, 25 Goldman Sachs
    Neutral
    Jun 17, 25 Citigroup
    Buy
    Jun 12, 25 Needham
    Buy
    Jun 10, 25 Stifel
    Buy
    May 8, 25 Needham
    Buy
    Apr 8, 25 Needham
    Buy
    Feb 27, 25 Scotiabank
    Sector Outperform
    Feb 27, 25 Needham
    Buy

    Institutional Ownership

    Screeners with NAMS included

    Growing Shares Outstanding
    Mid cap stocks
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    Best performing stocks last 3 years
    High Altman Z score stocks
    • What is the ticker symbol for NewAmsterdam Pharma Company N.V.?
    • Does NewAmsterdam Pharma Company N.V. pay dividends?
    • What sector is NewAmsterdam Pharma Company N.V. in?
    • What industry is NewAmsterdam Pharma Company N.V. in?
    • What country is NewAmsterdam Pharma Company N.V. based in?
    • When did NewAmsterdam Pharma Company N.V. go public?
    • Is NewAmsterdam Pharma Company N.V. in the S&P 500?
    • Is NewAmsterdam Pharma Company N.V. in the NASDAQ 100?
    • Is NewAmsterdam Pharma Company N.V. in the Dow Jones?
    • When was NewAmsterdam Pharma Company N.V.'s last earnings report?
    • When does NewAmsterdam Pharma Company N.V. report earnings?

    What is the ticker symbol for NewAmsterdam Pharma Company N.V.?

    The ticker symbol for NewAmsterdam Pharma Company N.V. is NASDAQ:NAMS

    Does NewAmsterdam Pharma Company N.V. pay dividends?

    No, NewAmsterdam Pharma Company N.V. does not pay dividends

    What sector is NewAmsterdam Pharma Company N.V. in?

    NewAmsterdam Pharma Company N.V. is in the Healthcare sector

    What industry is NewAmsterdam Pharma Company N.V. in?

    NewAmsterdam Pharma Company N.V. is in the Biotechnology industry

    What country is NewAmsterdam Pharma Company N.V. based in?

    NewAmsterdam Pharma Company N.V. is headquartered in Netherlands

    When did NewAmsterdam Pharma Company N.V. go public?

    NewAmsterdam Pharma Company N.V.'s initial public offering (IPO) was on February 9, 2021

    Is NewAmsterdam Pharma Company N.V. in the S&P 500?

    No, NewAmsterdam Pharma Company N.V. is not included in the S&P 500 index

    Is NewAmsterdam Pharma Company N.V. in the NASDAQ 100?

    No, NewAmsterdam Pharma Company N.V. is not included in the NASDAQ 100 index

    Is NewAmsterdam Pharma Company N.V. in the Dow Jones?

    No, NewAmsterdam Pharma Company N.V. is not included in the Dow Jones index

    When was NewAmsterdam Pharma Company N.V.'s last earnings report?

    NewAmsterdam Pharma Company N.V.'s most recent earnings report was on May 8, 2025

    When does NewAmsterdam Pharma Company N.V. report earnings?

    The next expected earnings date for NewAmsterdam Pharma Company N.V. is November 5, 2025
    On this page